Loading…

Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity

Polychlorinated biphenyls (PCBs) are persistent organic pollutants associated with metabolic disruption and nonalcoholic fatty liver disease (NAFLD). Based on their ability to activate the aryl hydrocarbon receptor (AhR), PCBs are subdivided into two classes: dioxin-like (DL) and non-dioxin-like (ND...

Full description

Saved in:
Bibliographic Details
Published in:Medicinal chemistry research 2020-07, Vol.29 (7), p.1247-1263
Main Authors: Jin, Jian, Wahlang, Banrida, Shi, Hongxue, Hardesty, Josiah E., Falkner, K. Cameron, Head, Kimberly Z., Srivastava, Sudhir, Merchant, Michael L., Rai, Shesh N., Cave, Matthew C., Prough, Russell A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c474t-b5c5360d3596c32c2389072aa6c342f83d16989594f8dac1e30de4a368cdab373
cites cdi_FETCH-LOGICAL-c474t-b5c5360d3596c32c2389072aa6c342f83d16989594f8dac1e30de4a368cdab373
container_end_page 1263
container_issue 7
container_start_page 1247
container_title Medicinal chemistry research
container_volume 29
creator Jin, Jian
Wahlang, Banrida
Shi, Hongxue
Hardesty, Josiah E.
Falkner, K. Cameron
Head, Kimberly Z.
Srivastava, Sudhir
Merchant, Michael L.
Rai, Shesh N.
Cave, Matthew C.
Prough, Russell A.
description Polychlorinated biphenyls (PCBs) are persistent organic pollutants associated with metabolic disruption and nonalcoholic fatty liver disease (NAFLD). Based on their ability to activate the aryl hydrocarbon receptor (AhR), PCBs are subdivided into two classes: dioxin-like (DL) and non-dioxin-like (NDL) PCBs. Previously, we demonstrated that NDL PCBs compromised the liver to promote more severe diet-induced NAFLD. Here, the hepatic effects and potential mechanisms (by untargeted liver proteomics) of DL PCBs and NDL PCBs or co-exposure to both in diet-induced NAFLD are investigated. Male C57Bl/6 mice were fed a 42% fat diet and exposed to vehicle control; Aroclor1260 (20 mg/kg, NDL PCB mixture); PCB126 (20 μg/kg, DL PCB congener); or a mixture of Aroclor1260 (20 mg/kg) + PCB126 (20 μg/kg) for 12 weeks. Each exposure was associated with a distinct hepatic proteome. Phenotypic and proteomic analyses revealed increased hepatic inflammation and phosphoprotein signaling disruption by Aroclor1260. PCB126 decreased hepatic inflammation and fibrosis at the molecular level; while altering cytoskeletal remodeling, metal homeostasis, and intermediary/xenobiotic metabolism. PCB126 attenuated Aroclor1260-induced hepatic inflammation but increased hepatic free fatty acids in the co-exposure group. Aroclor1260 + PCB126 exposure was strongly associated with multiple epigenetic processes, and these could potentially explain the observed nonadditive effects of the exposures on the hepatic proteome. Taken together, the results demonstrated that PCB exposures differentially regulated the hepatic proteome and the histologic severity of diet-induced NAFLD. Future research is warranted to determine the AhR-dependence of the observed effects including metal homeostasis and the epigenetic regulation of gene expression.
doi_str_mv 10.1007/s00044-020-02581-w
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7440142</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2417799659</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-b5c5360d3596c32c2389072aa6c342f83d16989594f8dac1e30de4a368cdab373</originalsourceid><addsrcrecordid>eNp9UctuFDEQtBARCYEf4IAscXbwcx4XJNgQiBQJDnC2vHbProN3vNiehPkOfjgmE5Jw4dDqbndVtVuF0CtGTxil7dtMKZWSUE5rqI6R6yfoiCklScc4fVprWmuuuDhEz3O-pFS0VKpn6FDwTjAl2BH6ferjLz-S4H8ANqPDYxyJe_T2dfUhY-eHARKMxZsQZpxgMwVTAJct4C3sTfEW71MsEHeLyi5Wylx5UIgf3WThVtkEG7cxVPRgSplx8FeQKiqDyYAz1M6X-QU6GEzI8PIuH6PvZx-_rT6Tiy-fzlfvL4iVrSxkrawSDXVC9Y0V3HLR9bTlxtRO8qETjjV916teDp0zloGgDqQRTWedWYtWHKN3i-5-Wu_A2XpfMkHvk9-ZNOtovP53Mvqt3sQr3UpJmeRV4M2dQIo_J8hFX8Yp1Suz5pK1bd83qq8ovqBsijknGO43MKr_GKkXI3U1Ut8aqa8r6fXjv91T_jpXAWIB5DoaN5Aedv9H9gb4-a18</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2417799659</pqid></control><display><type>article</type><title>Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity</title><source>Springer Link</source><creator>Jin, Jian ; Wahlang, Banrida ; Shi, Hongxue ; Hardesty, Josiah E. ; Falkner, K. Cameron ; Head, Kimberly Z. ; Srivastava, Sudhir ; Merchant, Michael L. ; Rai, Shesh N. ; Cave, Matthew C. ; Prough, Russell A.</creator><creatorcontrib>Jin, Jian ; Wahlang, Banrida ; Shi, Hongxue ; Hardesty, Josiah E. ; Falkner, K. Cameron ; Head, Kimberly Z. ; Srivastava, Sudhir ; Merchant, Michael L. ; Rai, Shesh N. ; Cave, Matthew C. ; Prough, Russell A.</creatorcontrib><description>Polychlorinated biphenyls (PCBs) are persistent organic pollutants associated with metabolic disruption and nonalcoholic fatty liver disease (NAFLD). Based on their ability to activate the aryl hydrocarbon receptor (AhR), PCBs are subdivided into two classes: dioxin-like (DL) and non-dioxin-like (NDL) PCBs. Previously, we demonstrated that NDL PCBs compromised the liver to promote more severe diet-induced NAFLD. Here, the hepatic effects and potential mechanisms (by untargeted liver proteomics) of DL PCBs and NDL PCBs or co-exposure to both in diet-induced NAFLD are investigated. Male C57Bl/6 mice were fed a 42% fat diet and exposed to vehicle control; Aroclor1260 (20 mg/kg, NDL PCB mixture); PCB126 (20 μg/kg, DL PCB congener); or a mixture of Aroclor1260 (20 mg/kg) + PCB126 (20 μg/kg) for 12 weeks. Each exposure was associated with a distinct hepatic proteome. Phenotypic and proteomic analyses revealed increased hepatic inflammation and phosphoprotein signaling disruption by Aroclor1260. PCB126 decreased hepatic inflammation and fibrosis at the molecular level; while altering cytoskeletal remodeling, metal homeostasis, and intermediary/xenobiotic metabolism. PCB126 attenuated Aroclor1260-induced hepatic inflammation but increased hepatic free fatty acids in the co-exposure group. Aroclor1260 + PCB126 exposure was strongly associated with multiple epigenetic processes, and these could potentially explain the observed nonadditive effects of the exposures on the hepatic proteome. Taken together, the results demonstrated that PCB exposures differentially regulated the hepatic proteome and the histologic severity of diet-induced NAFLD. Future research is warranted to determine the AhR-dependence of the observed effects including metal homeostasis and the epigenetic regulation of gene expression.</description><identifier>ISSN: 1054-2523</identifier><identifier>EISSN: 1554-8120</identifier><identifier>DOI: 10.1007/s00044-020-02581-w</identifier><identifier>PMID: 32831531</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Aromatic compounds ; Biochemistry ; Biomedical and Life Sciences ; Biomedicine ; Bioorganic Chemistry ; Congeners ; Cytoskeleton ; Diet ; Dioxins ; Disruption ; Epigenetics ; Exposure ; Fatty acids ; Fatty liver ; Fibrosis ; Gene expression ; Homeostasis ; Inflammation ; Inorganic Chemistry ; Liver ; Liver diseases ; Medicinal Chemistry ; Original Research ; PCB ; Persistent organic pollutants ; Pharmacology/Toxicology ; Pollutants ; Polychlorinated biphenyls ; Proteomes ; Proteomics</subject><ispartof>Medicinal chemistry research, 2020-07, Vol.29 (7), p.1247-1263</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-b5c5360d3596c32c2389072aa6c342f83d16989594f8dac1e30de4a368cdab373</citedby><cites>FETCH-LOGICAL-c474t-b5c5360d3596c32c2389072aa6c342f83d16989594f8dac1e30de4a368cdab373</cites><orcidid>0000-0001-8901-8490</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32831531$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jin, Jian</creatorcontrib><creatorcontrib>Wahlang, Banrida</creatorcontrib><creatorcontrib>Shi, Hongxue</creatorcontrib><creatorcontrib>Hardesty, Josiah E.</creatorcontrib><creatorcontrib>Falkner, K. Cameron</creatorcontrib><creatorcontrib>Head, Kimberly Z.</creatorcontrib><creatorcontrib>Srivastava, Sudhir</creatorcontrib><creatorcontrib>Merchant, Michael L.</creatorcontrib><creatorcontrib>Rai, Shesh N.</creatorcontrib><creatorcontrib>Cave, Matthew C.</creatorcontrib><creatorcontrib>Prough, Russell A.</creatorcontrib><title>Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity</title><title>Medicinal chemistry research</title><addtitle>Med Chem Res</addtitle><addtitle>Med Chem Res</addtitle><description>Polychlorinated biphenyls (PCBs) are persistent organic pollutants associated with metabolic disruption and nonalcoholic fatty liver disease (NAFLD). Based on their ability to activate the aryl hydrocarbon receptor (AhR), PCBs are subdivided into two classes: dioxin-like (DL) and non-dioxin-like (NDL) PCBs. Previously, we demonstrated that NDL PCBs compromised the liver to promote more severe diet-induced NAFLD. Here, the hepatic effects and potential mechanisms (by untargeted liver proteomics) of DL PCBs and NDL PCBs or co-exposure to both in diet-induced NAFLD are investigated. Male C57Bl/6 mice were fed a 42% fat diet and exposed to vehicle control; Aroclor1260 (20 mg/kg, NDL PCB mixture); PCB126 (20 μg/kg, DL PCB congener); or a mixture of Aroclor1260 (20 mg/kg) + PCB126 (20 μg/kg) for 12 weeks. Each exposure was associated with a distinct hepatic proteome. Phenotypic and proteomic analyses revealed increased hepatic inflammation and phosphoprotein signaling disruption by Aroclor1260. PCB126 decreased hepatic inflammation and fibrosis at the molecular level; while altering cytoskeletal remodeling, metal homeostasis, and intermediary/xenobiotic metabolism. PCB126 attenuated Aroclor1260-induced hepatic inflammation but increased hepatic free fatty acids in the co-exposure group. Aroclor1260 + PCB126 exposure was strongly associated with multiple epigenetic processes, and these could potentially explain the observed nonadditive effects of the exposures on the hepatic proteome. Taken together, the results demonstrated that PCB exposures differentially regulated the hepatic proteome and the histologic severity of diet-induced NAFLD. Future research is warranted to determine the AhR-dependence of the observed effects including metal homeostasis and the epigenetic regulation of gene expression.</description><subject>Aromatic compounds</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Bioorganic Chemistry</subject><subject>Congeners</subject><subject>Cytoskeleton</subject><subject>Diet</subject><subject>Dioxins</subject><subject>Disruption</subject><subject>Epigenetics</subject><subject>Exposure</subject><subject>Fatty acids</subject><subject>Fatty liver</subject><subject>Fibrosis</subject><subject>Gene expression</subject><subject>Homeostasis</subject><subject>Inflammation</subject><subject>Inorganic Chemistry</subject><subject>Liver</subject><subject>Liver diseases</subject><subject>Medicinal Chemistry</subject><subject>Original Research</subject><subject>PCB</subject><subject>Persistent organic pollutants</subject><subject>Pharmacology/Toxicology</subject><subject>Pollutants</subject><subject>Polychlorinated biphenyls</subject><subject>Proteomes</subject><subject>Proteomics</subject><issn>1054-2523</issn><issn>1554-8120</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9UctuFDEQtBARCYEf4IAscXbwcx4XJNgQiBQJDnC2vHbProN3vNiehPkOfjgmE5Jw4dDqbndVtVuF0CtGTxil7dtMKZWSUE5rqI6R6yfoiCklScc4fVprWmuuuDhEz3O-pFS0VKpn6FDwTjAl2BH6ferjLz-S4H8ANqPDYxyJe_T2dfUhY-eHARKMxZsQZpxgMwVTAJct4C3sTfEW71MsEHeLyi5Wylx5UIgf3WThVtkEG7cxVPRgSplx8FeQKiqDyYAz1M6X-QU6GEzI8PIuH6PvZx-_rT6Tiy-fzlfvL4iVrSxkrawSDXVC9Y0V3HLR9bTlxtRO8qETjjV916teDp0zloGgDqQRTWedWYtWHKN3i-5-Wu_A2XpfMkHvk9-ZNOtovP53Mvqt3sQr3UpJmeRV4M2dQIo_J8hFX8Yp1Suz5pK1bd83qq8ovqBsijknGO43MKr_GKkXI3U1Ut8aqa8r6fXjv91T_jpXAWIB5DoaN5Aedv9H9gb4-a18</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Jin, Jian</creator><creator>Wahlang, Banrida</creator><creator>Shi, Hongxue</creator><creator>Hardesty, Josiah E.</creator><creator>Falkner, K. Cameron</creator><creator>Head, Kimberly Z.</creator><creator>Srivastava, Sudhir</creator><creator>Merchant, Michael L.</creator><creator>Rai, Shesh N.</creator><creator>Cave, Matthew C.</creator><creator>Prough, Russell A.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>M7Z</scope><scope>P64</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8901-8490</orcidid></search><sort><creationdate>20200701</creationdate><title>Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity</title><author>Jin, Jian ; Wahlang, Banrida ; Shi, Hongxue ; Hardesty, Josiah E. ; Falkner, K. Cameron ; Head, Kimberly Z. ; Srivastava, Sudhir ; Merchant, Michael L. ; Rai, Shesh N. ; Cave, Matthew C. ; Prough, Russell A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-b5c5360d3596c32c2389072aa6c342f83d16989594f8dac1e30de4a368cdab373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aromatic compounds</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Bioorganic Chemistry</topic><topic>Congeners</topic><topic>Cytoskeleton</topic><topic>Diet</topic><topic>Dioxins</topic><topic>Disruption</topic><topic>Epigenetics</topic><topic>Exposure</topic><topic>Fatty acids</topic><topic>Fatty liver</topic><topic>Fibrosis</topic><topic>Gene expression</topic><topic>Homeostasis</topic><topic>Inflammation</topic><topic>Inorganic Chemistry</topic><topic>Liver</topic><topic>Liver diseases</topic><topic>Medicinal Chemistry</topic><topic>Original Research</topic><topic>PCB</topic><topic>Persistent organic pollutants</topic><topic>Pharmacology/Toxicology</topic><topic>Pollutants</topic><topic>Polychlorinated biphenyls</topic><topic>Proteomes</topic><topic>Proteomics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jin, Jian</creatorcontrib><creatorcontrib>Wahlang, Banrida</creatorcontrib><creatorcontrib>Shi, Hongxue</creatorcontrib><creatorcontrib>Hardesty, Josiah E.</creatorcontrib><creatorcontrib>Falkner, K. Cameron</creatorcontrib><creatorcontrib>Head, Kimberly Z.</creatorcontrib><creatorcontrib>Srivastava, Sudhir</creatorcontrib><creatorcontrib>Merchant, Michael L.</creatorcontrib><creatorcontrib>Rai, Shesh N.</creatorcontrib><creatorcontrib>Cave, Matthew C.</creatorcontrib><creatorcontrib>Prough, Russell A.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicinal chemistry research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jin, Jian</au><au>Wahlang, Banrida</au><au>Shi, Hongxue</au><au>Hardesty, Josiah E.</au><au>Falkner, K. Cameron</au><au>Head, Kimberly Z.</au><au>Srivastava, Sudhir</au><au>Merchant, Michael L.</au><au>Rai, Shesh N.</au><au>Cave, Matthew C.</au><au>Prough, Russell A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity</atitle><jtitle>Medicinal chemistry research</jtitle><stitle>Med Chem Res</stitle><addtitle>Med Chem Res</addtitle><date>2020-07-01</date><risdate>2020</risdate><volume>29</volume><issue>7</issue><spage>1247</spage><epage>1263</epage><pages>1247-1263</pages><issn>1054-2523</issn><eissn>1554-8120</eissn><abstract>Polychlorinated biphenyls (PCBs) are persistent organic pollutants associated with metabolic disruption and nonalcoholic fatty liver disease (NAFLD). Based on their ability to activate the aryl hydrocarbon receptor (AhR), PCBs are subdivided into two classes: dioxin-like (DL) and non-dioxin-like (NDL) PCBs. Previously, we demonstrated that NDL PCBs compromised the liver to promote more severe diet-induced NAFLD. Here, the hepatic effects and potential mechanisms (by untargeted liver proteomics) of DL PCBs and NDL PCBs or co-exposure to both in diet-induced NAFLD are investigated. Male C57Bl/6 mice were fed a 42% fat diet and exposed to vehicle control; Aroclor1260 (20 mg/kg, NDL PCB mixture); PCB126 (20 μg/kg, DL PCB congener); or a mixture of Aroclor1260 (20 mg/kg) + PCB126 (20 μg/kg) for 12 weeks. Each exposure was associated with a distinct hepatic proteome. Phenotypic and proteomic analyses revealed increased hepatic inflammation and phosphoprotein signaling disruption by Aroclor1260. PCB126 decreased hepatic inflammation and fibrosis at the molecular level; while altering cytoskeletal remodeling, metal homeostasis, and intermediary/xenobiotic metabolism. PCB126 attenuated Aroclor1260-induced hepatic inflammation but increased hepatic free fatty acids in the co-exposure group. Aroclor1260 + PCB126 exposure was strongly associated with multiple epigenetic processes, and these could potentially explain the observed nonadditive effects of the exposures on the hepatic proteome. Taken together, the results demonstrated that PCB exposures differentially regulated the hepatic proteome and the histologic severity of diet-induced NAFLD. Future research is warranted to determine the AhR-dependence of the observed effects including metal homeostasis and the epigenetic regulation of gene expression.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>32831531</pmid><doi>10.1007/s00044-020-02581-w</doi><tpages>17</tpages><orcidid>https://orcid.org/0000-0001-8901-8490</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1054-2523
ispartof Medicinal chemistry research, 2020-07, Vol.29 (7), p.1247-1263
issn 1054-2523
1554-8120
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7440142
source Springer Link
subjects Aromatic compounds
Biochemistry
Biomedical and Life Sciences
Biomedicine
Bioorganic Chemistry
Congeners
Cytoskeleton
Diet
Dioxins
Disruption
Epigenetics
Exposure
Fatty acids
Fatty liver
Fibrosis
Gene expression
Homeostasis
Inflammation
Inorganic Chemistry
Liver
Liver diseases
Medicinal Chemistry
Original Research
PCB
Persistent organic pollutants
Pharmacology/Toxicology
Pollutants
Polychlorinated biphenyls
Proteomes
Proteomics
title Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T01%3A50%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dioxin-like%20and%20non-dioxin-like%20PCBs%20differentially%20regulate%20the%20hepatic%20proteome%20and%20modify%20diet-induced%20nonalcoholic%20fatty%20liver%20disease%20severity&rft.jtitle=Medicinal%20chemistry%20research&rft.au=Jin,%20Jian&rft.date=2020-07-01&rft.volume=29&rft.issue=7&rft.spage=1247&rft.epage=1263&rft.pages=1247-1263&rft.issn=1054-2523&rft.eissn=1554-8120&rft_id=info:doi/10.1007/s00044-020-02581-w&rft_dat=%3Cproquest_pubme%3E2417799659%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c474t-b5c5360d3596c32c2389072aa6c342f83d16989594f8dac1e30de4a368cdab373%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2417799659&rft_id=info:pmid/32831531&rfr_iscdi=true